Skip to main content

25-05-2020 | Multiple sclerosis | Video

EAN 2020 | Clinical data support benefits of relapse prevention on QoL in NMOSD patients

Michael Levy discusses findings from the SAkura studies confirming a strong and consistent relationship between disability and quality of life in patients with neuromyelitis optica spectrum disorder (2:25).

Funding for independent interviews at EAN 2020 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.